MXPA05005414A - Derivados de propargil-trifluorometoxi-amino-benzotiazol. - Google Patents

Derivados de propargil-trifluorometoxi-amino-benzotiazol.

Info

Publication number
MXPA05005414A
MXPA05005414A MXPA05005414A MXPA05005414A MXPA05005414A MX PA05005414 A MXPA05005414 A MX PA05005414A MX PA05005414 A MXPA05005414 A MX PA05005414A MX PA05005414 A MXPA05005414 A MX PA05005414A MX PA05005414 A MXPA05005414 A MX PA05005414A
Authority
MX
Mexico
Prior art keywords
present
integer
alkyl
propargyl
trifluoromethoxy
Prior art date
Application number
MXPA05005414A
Other languages
English (en)
Spanish (es)
Inventor
David Lerner
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of MXPA05005414A publication Critical patent/MXPA05005414A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MXPA05005414A 2002-11-21 2003-11-20 Derivados de propargil-trifluorometoxi-amino-benzotiazol. MXPA05005414A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30154002A 2002-11-21 2002-11-21
PCT/US2003/037592 WO2004047756A2 (en) 2002-11-21 2003-11-20 Propargyl-trifluoromethoxy-amino-benzothiazole derivatives

Publications (1)

Publication Number Publication Date
MXPA05005414A true MXPA05005414A (es) 2006-05-25

Family

ID=32392394

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05005414A MXPA05005414A (es) 2002-11-21 2003-11-20 Derivados de propargil-trifluorometoxi-amino-benzotiazol.

Country Status (13)

Country Link
EP (1) EP1569641A2 (is)
JP (1) JP2006507350A (is)
KR (1) KR20050083951A (is)
CN (1) CN1741802A (is)
AU (1) AU2003295898A1 (is)
BR (1) BR0315704A (is)
CA (1) CA2507414A1 (is)
IS (1) IS7906A (is)
MX (1) MXPA05005414A (is)
NO (1) NO20052979L (is)
RU (1) RU2005119307A (is)
WO (1) WO2004047756A2 (is)
ZA (1) ZA200504988B (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012050971A2 (en) * 2010-09-29 2012-04-19 Teva Pharmaceutical Industries Ltd. Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and use
CN103340859A (zh) * 2013-06-04 2013-10-09 中国科学院昆明动物研究所 侧脑室mpp+给药建立非人灵长类帕金森病动物模型的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59112978A (ja) * 1982-12-21 1984-06-29 Shionogi & Co Ltd プロピニルアミノチアゾ−ル誘導体

Also Published As

Publication number Publication date
CN1741802A (zh) 2006-03-01
EP1569641A2 (en) 2005-09-07
RU2005119307A (ru) 2006-01-27
AU2003295898A1 (en) 2004-06-18
JP2006507350A (ja) 2006-03-02
WO2004047756A2 (en) 2004-06-10
WO2004047756A3 (en) 2004-07-08
NO20052979L (no) 2005-08-19
NO20052979D0 (no) 2005-06-17
IS7906A (is) 2005-06-22
BR0315704A (pt) 2005-09-06
CA2507414A1 (en) 2004-06-10
KR20050083951A (ko) 2005-08-26
ZA200504988B (en) 2006-08-30

Similar Documents

Publication Publication Date Title
TWI262805B (en) Pharmaceutical composition for treating or inhibiting colonic polyps
TW369526B (en) Diazabicyclic neurokinin antagonists
MY140525A (en) Pharmaceutical uses for alpha2delta ligands
MXPA04000411A (es) Tiazolidinonas arilo sustituidas y uso de las mismas.
IL154272A (en) Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
MXPA03001518A (es) Composicion y metodo para inhibir la agregacion plaquetaria.
GR3034520T3 (en) 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors
AU4696897A (en) Neurotrophin antagonist compositions
ZA953976B (en) 11,21-bisphenyl-19-norpregnane derivatives
CA2064853A1 (en) Indole derivatives
NZ331801A (en) Therapeutic agent for diabetes
IL108695A (en) Pharmaceutical composition comprising polyamine derivatives and some such novel compounds
GB9727521D0 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
SG146681A1 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
MXPA05005414A (es) Derivados de propargil-trifluorometoxi-amino-benzotiazol.
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
TW427993B (en) New cephem compounds
WO2004054565A8 (en) Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders
MY144338A (en) Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
TW327598B (en) N-acetonylbenzamide fungicides
MY129094A (en) Condensed polycyclic compounds
MXPA03010407A (es) Prevencion de adiccion en gestion del dolor.
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
NZ334317A (en) beta-lactam compounds as antibacterial agents effective against methicillin-resistant and coagulase-negative Staphylococci and process for preparing the same
AP2002002595A0 (en) Heterocyclic amide derivatives.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal